TEVA-Betahistine Tablets: Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine.

Brand(s)

Last updated

2024-12-04

Summary

Product

TEVA-Betahistine Tablets

Issue

Health products - Product safety

What to do

Consult your health care professional if you have any health concerns.

Brand	Product Name	Market Authorization	Dosage Form	Strength	Lot
TEVA-Betahistine Tablets	TEVA-Betahistine Tablets 8mg	DIN 02280183	Tablet	BETAHISTINE HYDROCHLORIDE 8mg	100043755 100047041 100054115 100057407
TEVA-Betahistine Tablets	TEVA-Betahistine Tablets 16mg	DIN 02280191	Tablet	BETAHISTINE HYDROCHLORIDE 16mg	100039202 100039975 100040342 100047037 100047038 100048555 100050930 100052559 100057107 100057408 100058036 100062444 100038357 100047367
TEVA-Betahistine Tablets	TEVA-Betahistine Tablets 24mg	DIN 02280205	Tablet	BETAHISTINE HYDROCHLORIDE 24mg	100038340 100043738 100049891 100052857 100056000 100039609 100039610 100039611 100044222 100049365 100058037

Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine.

Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.

Background

Depth of recall: Retailers, Pharmacy

Details

Original published date: 2024-12-04

Alert / recall type

Health product recall

Receive notifications for new and updated recalls and alerts by category.